U.S. Gas Utilities Stock News

NasdaqGS:KHC
NasdaqGS:KHCFood

Kraft Heinz (KHC) Q1 Profit Of US$798m Tests Longstanding Loss Narrative

Kraft Heinz (KHC) opened 2026 with Q1 revenue of US$6.0b, basic EPS of US$0.67 and net income of US$798m, setting the tone for how the rest of the year might shape up for shareholders watching profitability closely. The company has seen quarterly revenue move from US$6.6b in Q4 2024 to US$6.0b in Q1 2026, while basic EPS shifted from US$1.77 to US$0.67 over the same period, against a backdrop of trailing twelve month losses and only modest revenue growth. With analysts in the supplied data...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

NVIDIA Corning Deal Links AI Growth Story With Valuation Questions

NVIDIA (NasdaqGS: NVDA) announced a multiyear partnership with Corning to expand U.S. manufacturing for next generation AI data center optical connectivity. The plan includes three new U.S. plants, a targeted 10x capacity increase, and over 3,000 new jobs tied to advanced optical components for AI infrastructure. The agreement spans supply commitments and equity links, reflecting deeper integration between NVIDIA and a key optical technology supplier. NVIDIA, best known for its GPUs and AI...
NYSE:KO
NYSE:KOBeverage

How Investors Are Reacting To Coca-Cola (KO) Earnings Beat, Dividend Payout And ESG Proposal Rejections

In the past week, The Coca-Cola Company reported first-quarter 2026 results with sales of US$12.47 billion and net income of US$3.92 billion, alongside affirming a quarterly dividend of US$0.53 per share payable on 1 July 2026. At the same time, shareholders rejected multiple proposals on sustainability, ingredient risks, plastics packaging, and diversity reporting, highlighting an ongoing tension between environmental, social, and governance advocates and the prevailing priorities of the...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Should Axon’s Raised 2026 Outlook and AI‑Driven Growth Require Action From Axon Enterprise (AXON) Investors?

Axon Enterprise reported past first-quarter 2026 results with revenue of US$807.35 million and net income of US$169.31 million, significantly higher than a year earlier and ahead of revenue expectations. Management’s decision to raise full-year revenue guidance, underpinned by rapid growth in AI-driven offerings and its expanding counter-drone business, highlights how newer product lines are becoming central to Axon’s business mix. We’ll now examine how Axon’s raised full-year revenue...
NasdaqGS:OTTR
NasdaqGS:OTTRElectric Utilities

Is It Time To Reassess Otter Tail (OTTR) After Its Strong Multi Year Share Price Run

Wondering if Otter Tail is fairly priced or if the stock is offering value at its current level of US$88.89? This article breaks down what the numbers are really saying. The stock has returned 0.8% over the last week, 0.4% over the past month, 9.1% year to date and 19.5% over the last year, with a 3 year return of 21.1% and a 5 year return of 114.0%. This provides plenty of history to weigh against today's price. Recent coverage has focused on Otter Tail in the context of evergreen analysis,...
NasdaqGS:WDC
NasdaqGS:WDCTech

Is It Too Late To Reassess Western Digital (WDC) After Its Surging Share Price?

If you are wondering whether Western Digital's recent surge still offers value, the stock's current set up makes it a prime candidate for a closer look at what you are actually paying for its future cash flows. Western Digital closed at US$483.15, with returns of 17.1% over 7 days, 58.9% over 30 days and 157.4% year to date, while the 1 year and 3 year returns are very large, with the 3 year return approaching 20x the starting point. Recent coverage has focused on Western Digital's position...
NYSE:RH
NYSE:RHSpecialty Retail

Assessing RH (RH) Valuation After Recent Share Price Volatility And Mixed Long Term Returns

RH stock performance snapshot RH (RH) has caught investor attention after a choppy year, with the stock showing a 6.7% move over the past day and mixed returns across the week, month, and past 3 months. Shares last closed at US$131.73, with year to date and 1 year total returns both negative, and longer term 3 year and 5 year total returns also in decline, prompting closer scrutiny of the company’s fundamentals. See our latest analysis for RH. The recent 1 day share price return of 6.7% and 1...
NYSE:MOS
NYSE:MOSChemicals

Is Mosaic (MOS) Attractive After Recent Share Price Weakness And DCF Valuation Gap?

If you are wondering whether Mosaic, at a last close of US$23.56, looks cheap or expensive right now, this article walks through what that price implies about the stock. The stock has been choppy, with a 2.3% return over the last 7 days, an 11.1% decline over 30 days, and a 23.1% decline over the past year, which can change how the market views both its potential and its risks. Recent news coverage has focused on Mosaic in the context of broader materials and commodity sentiment, including...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

A Look At Halozyme Therapeutics (HALO) Valuation After Recent Share Price Swings

Halozyme Therapeutics Stock Moves After Recent Performance Shifts Halozyme Therapeutics (HALO) has drawn fresh attention after a mixed stretch in its share performance, including a month gain of about 5% alongside a past 3 months decline of roughly 15%. See our latest analysis for Halozyme Therapeutics. With the share price at about $66.35, Halozyme Therapeutics shows short term momentum, with a 7 day share price return of 5.22%. However, the year to date share price return of a 5.63% decline...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Coinbase Leans On AI And Job Cuts As Profitability Test Looms

Coinbase Global (NasdaqGS:COIN) is cutting roughly 14% of its global workforce. The company is reorganizing operations around greater AI adoption across core functions. The restructuring is framed as a push for efficiency and cost discipline in a challenging crypto market. For investors tracking Coinbase Global, the restructuring comes at a time when the stock is trading at $197.96, with a 7 day return of 8.9% and a 30 day return of 13.3%. Over 3 years, the stock has delivered a gain of...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

E-Commerce Update - Shopify's Impressive Growth Fueled By Strategic Investments

E-commerce platform Shopify reported significant milestones for the first quarter of 2026, with merchants on its platform generating over $100 billion in Gross Merchandise Volume (GMV). The company's financial performance sees a notable 34% revenue growth alongside consistent free cash flow margins. These results highlight broad-based growth across different geographies, merchant sizes, and channels, underscoring Shopify's strategic investments in enhancing merchant tools and internal...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) Is Up 17.1% After Blowout Q3 Earnings and Dividend Hike - What's Changed

In late April 2026, Western Digital Corporation reported fiscal third-quarter sales of US$3,337 million and net income of US$3,205 million, alongside a 20% increase in its quarterly cash dividend to US$0.15 per share, payable on June 17, 2026, to shareholders of record on June 5, 2026. The combination of sharply higher earnings and a dividend hike, set against surging AI-related storage demand and strengthened cloud partnerships, signals how central Western Digital has become to the...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Is Up 11.9% After Raising 2026 Guidance On Early Lifyorli Uptake

In late April 2026, Corcept Therapeutics reported a first-quarter net loss of US$31.76 million versus net income of US$20.55 million a year earlier, while also raising its 2026 revenue guidance to US$950 million–US$1.05 billion on the back of strong prescription trends and the early FDA approval of Lifyorli for platinum-resistant ovarian cancer. At the same time, promising long-term survival data from the Phase 2 DAZALS trial in ALS and an advancing cortisol-modulation pipeline highlight how...
NYSE:F
NYSE:FAuto

Is Ford (F) Fairly Priced After Mixed Returns And Conflicting Valuation Signals

To understand whether Ford Motor stock offers good value at today’s price, you first need to know how that price compares with key measures like cash flows, earnings and assets, not just the headline share chart. Over the last week the stock recorded a 0.6% decline, while the 30 day return stands at 4.8%. The year to date return is an 8.8% decline and the 1 year return is 24.5%, with 3 and 5 year returns of 22.1% and 43.1% respectively. Recent coverage around Ford Motor has focused on broader...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Is Patterson-UTI (PTEN) Quietly Recasting Its Risk Profile With New Debt And Shifting Shareholders?

In early May 2026, Patterson-UTI Energy completed a US$499.27 million offering of 6.050% senior unsecured notes due 2036 and extended US$450 million of its revolving credit facility to 2031, reinforcing balance sheet flexibility following a quarter in which earnings and revenue exceeded expectations. Alongside these financing moves, a series of routine insider stock sales and equity awards occurred while an affiliate of Blackstone reduced its ownership below 5%, highlighting an ongoing...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) Valuation Check After AI Shift And US$1.0b Stock Offering

TeraWulf (WULF) has drawn fresh attention after closing a US$1.0b stock offering to fund a large AI focused data center project in Kentucky, alongside a well publicized shift away from purely bitcoin mining. See our latest analysis for TeraWulf. The recent US$1.0b stock offering and pivot toward AI focused infrastructure have coincided with very strong momentum. The 30 day share price return is 65.53% and the year to date share price return is 102.04%, on top of a very large 1 year total...
NasdaqGS:CABA
NasdaqGS:CABABiotechs

Cabaletta Bio (CABA) Is Up 34.2% After Early RESET-PV Data And US$150M Equity Raise

In early May 2026, Cabaletta Bio reported early RESET-PV trial data showing biologic and clinical activity for its rese-cel CAR T therapy in refractory pemphigus vulgaris patients treated at the lowest dose without chemotherapy preconditioning, alongside a completed US$150.00 million follow-on equity offering priced at US$2.90 per share. An interesting angle for investors is Cabaletta’s 10-year commercial supply agreement with Cellares, which aims to support automated, higher-throughput...
NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

Is It Too Late To Consider Ensign Group (ENSG) After Its Recent Pullback?

If you are wondering whether Ensign Group's current share price lines up with its underlying worth, you are not alone in asking if the stock still offers value after its recent run. The stock closed at US$175.93, with returns of 28.7% over 1 year and 117.5% over 5 years, although the past month shows an 11.1% pullback and a 5.6% decline over 7 days, leaving year to date returns at 1.2%. Recent attention on Ensign Group has centered on how the market is reassessing healthcare operators and...